CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	6 Months Ended
Dec. 31, 2014	Dec. 31, 2013
Statement of Cash Flows [Abstract]
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	$ 8,558	$ 5,947
OPERATING ACTIVITIES
NET EARNINGS	4,418us-gaap_ProfitLoss	6,529us-gaap_ProfitLoss
Depreciation and amortization	1,540us-gaap_DepreciationAndAmortization	1,526us-gaap_DepreciationAndAmortization
Share-based compensation expense	151us-gaap_ShareBasedCompensation	153us-gaap_ShareBasedCompensation
Deferred income taxes	31us-gaap_DeferredIncomeTaxExpenseBenefit	(126)us-gaap_DeferredIncomeTaxExpenseBenefit
(Gain)/loss on sale of businesses	(299)us-gaap_GainLossOnSaleOfBusiness	(5)us-gaap_GainLossOnSaleOfBusiness
Goodwill and indefinite lived intangibles impairment charges	1,713	0
Changes in:
Accounts receivable	(342)	(376)
Inventories	(506)us-gaap_IncreaseDecreaseInInventories	(446)us-gaap_IncreaseDecreaseInInventories
Accounts payable, accrued and other liabilities	243	(1,191)
Other operating assets and liabilities	(164)	(859)
Other	283us-gaap_OtherNoncashIncomeExpense	138us-gaap_OtherNoncashIncomeExpense
TOTAL OPERATING ACTIVITIES	7,068	5,343
INVESTING ACTIVITIES
Capital expenditures	(1,642)	(1,663)
Proceeds from asset sales	3,648	15
Acquisitions, net of cash acquired	(112)	1
Purchases of available-for-sale investment securities	(2,106)	0
Proceeds from sales of available-for-sale investment securities	179	0
Change in investments	(836)	(149)
TOTAL INVESTING ACTIVITIES	(869)	(1,796)
FINANCING ACTIVITIES
Dividends to shareholders	(3,614)us-gaap_PaymentsOfDividends	(3,409)us-gaap_PaymentsOfDividends
Change in short-term debt	352	(429)
Additions to long-term debt	1,112	4,271
Reductions of long-term debt	(1,911)us-gaap_RepaymentsOfLongTermDebt	(3)us-gaap_RepaymentsOfLongTermDebt
Treasury stock purchases	(4,253)	(4,004)
Impact of stock options and other	2,009	937
TOTAL FINANCING ACTIVITIES	(6,305)	(2,637)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(248)	72
CHANGE IN CASH AND CASH EQUIVALENTS	(354)	982
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 8,204	$ 6,929

Impairment recognized during the period and allocated to the reportable segment that results from the write-down of goodwill and indefinite-lived intangible assets after comparing the implied fair value of reporting unit goodwill and indefinite-lived intangible assets with the carrying amount of that goodwill and indefinite-lived intangible assets, which are assessed at least annually for impairment.

No definition available.